Journal Home
Search for

Volume 16, Issue 2, Pages 71-77 (February 2006)


View previous. 4 of 16 View next.

Noninvasive Arterial Measurements of Vascular Damage in Healthy Young Adults: Relation to Coronary Heart Disease Risk

Marijke J.C.A. Van Trijp, MD, Cuno S.P.M. Uiterwaal, MD, PhD, Willem J.W. Bos, MD, PhD, Anath Oren, MD, PhD, Diederick E. Grobbee, MD, PhD, Michiel L. Bots, MD, PhDCorresponding Author Informationemail address

Received 26 May 2005; accepted 5 September 2005. published online 22 November 2005.

Purpose

There is an increasing interest in noninvasive measurements of early structural or functional changes in large arteries such as pulse wave velocity (PWV), carotid intima-media thickness (CIMT), and augmentation index (AIx). These measurements may be applied in etiologic or prognostic research. The role of the AIx as a marker of cardiovascular risk has not fully been established. Our aim was to study whether AIx is related to coronary heart disease (CHD) risk and to compare the strength of the relations of AIx, PWV, and CIMT with cardiovascular risk in healthy young adults.

Methods

Our study included 224 men and 273 women (mean age 28 years, range 27–30 years) from the Atherosclerosis Risk in Young Adults (ARYA) study. Cardiovascular risk profile was determined and CHD risk was estimated using the Framingham risk score. AIx, PWV and CIMT were measured using standard methods. Data were analyzed in strata of gender using linear regression models.

Results

In men, PWV and CIMT were most strongly related to CHD risk. The increase in CHD risk per standard deviation increase in measurement was 0.24%/m/s, 95% CI (0.01;0.33) and 0.32%/mm, 95% CI (0.08;0.55), whereas the AIx was not significantly related to CHD risk (0.09 %/% 95% CI [–0.15;0.33]). In women, AIx, PWV, and CIMT were weakly but significantly related to CHD risk; there was no clear difference between the measurements.

Conclusion

In young men, PWV and CIMT are better measures of CHD risk than AIx. In women, AIx, PWV and CIMT estimate CHD risk equally well.

From Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands (J.C.A., C.S.P.M.U., A.O., D.E.G.); and Dept. of Internal Medicine, St. Antonius Hospital, Nieuwegein, The Netherlands (W.J.W.B.)

Corresponding Author InformationAddress correspondence and requests for reprints to M.L. Bots, MD, Ph.D., Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, Str. 6.131Universiteitsweg 100 3584 CG, Utrecht, The Netherlands. Tel.: (00-31) 30-250-9352; fax: (00-31) 30-250-5485.

PII: S1047-2797(05)00322-4

doi:10.1016/j.annepidem.2005.09.005


View previous. 4 of 16 View next.